Last reviewed · How we verify
NCT02629107
Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli
trial in Normal Physiology in 2,378 participants. Currently enrolling.
31 December 2044
Quick facts
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,378 |
| Start date | 14 January 2016 |
| Primary completion | 31 December 2044 |
| Estimated completion | 31 December 2045 |
| Sites | 1 location across United States |
Conditions studied
- Normal Physiology — all drugs for Normal Physiology →
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Who can join
Adults 18 to 34, any sex, with Normal Physiology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: An electroencephalogram (EEG) measures the brain s electrical activity. EEG shows that the louder the sound needed to wake a person, the deeper the person s sleep. Researchers are using functional magnetic resonance imaging (fMRI) to study people during sleep so they can view brain activity in 3D. But they still need to correlate fMRI with sound thresholds, like the EEG. Objective: To measure brain activity during sleep using fMRI and EEG. Eligibility: Healthy people ages 18 34 who can sleep on their back for several hours. Design: Participants will be screened online about their sleep and general health. At a screening visit, participants will have: Physical exam Hearing exam MRI scan. A strong magnetic field and radio waves take pictures of the brain. Participants will lie down on a bed that slides into the scanner, which is shaped like a cylinder. Participants will wear an actigraph on their wrist that records their motor activity. Participants will follow a 2-week routine. This includes regular in-to-bed and out-of-bed times and limits on alcohol, caffeine, and nicotine. During the overnight visits, participants will have: Female subjects will have a urine pregnancy test. fMRI. A coil will be placed over the head. Participants will do tasks shown on a computer screen inside the scanner. EEG. Small electrodes on the scalp will record brain waves while sleeping or doing a task in the scanner. Participants will be asked to try to sleep while researchers collect fMRI and EEG data. Participants eyes will be monitored with a video camera. Headphones will deliver sounds to wake them up throughout the night. ...
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
All-night functional magnetic resonance imaging sleep studies.
Moehlman TM, de Zwart JA, Chappel-Farley MG, Liu X, et al · · 2019 · cited 36× · PMID 30243817 · DOI 10.1016/j.jneumeth.2018.09.019 -
Sleep-stage dependent patterning of slowly propagating brain activity.
Liu X, Picchioni D, Yang Y, Mandelkow H, et al · · 2025 · cited 2× · PMID 41776265 · DOI 10.1038/s44323-024-00017-x
Verify or expand the search:
- PubMed search for NCT02629107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Normal Physiology
Currently open trials in the same condition.
- NCT06561828 — Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making · EARLY_PHASE1 · recruiting
- NCT05666739 — NIEHS Repository of Stored Biological Samples for Future Use · recruiting
- NCT05829044 — Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms · NA · recruiting
- NCT06050603 — MRI Guided Closed-loop TMS-EEG · NA · recruiting
- NCT05545306 — The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure · NA · recruiting
Other National Institute of Neurological Disorders and Stroke (NINDS) trials
Trials by the same sponsor.
- NCT07137442 — Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques · recruiting
- NCT02522611 — Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07511049 — Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study · Phase 2 · not yet recruiting
- NCT07416188 — Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · Phase 1, PHASE2 · not yet recruiting
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02629107 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Neurological Disorders and Stroke (NINDS)
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02629107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing